shaw science case studies
TRANSCRIPT
![Page 1: Shaw Science Case Studies](https://reader034.vdocuments.mx/reader034/viewer/2022042715/5597a0da1a28abac098b4657/html5/thumbnails/1.jpg)
T h i s i s S c i e n c e B r a n d i n g ™
T h i s i s w h a t w e d o .
![Page 2: Shaw Science Case Studies](https://reader034.vdocuments.mx/reader034/viewer/2022042715/5597a0da1a28abac098b4657/html5/thumbnails/2.jpg)
Diovan Case S tudy
T h i s i s w h a t w e d o .
![Page 3: Shaw Science Case Studies](https://reader034.vdocuments.mx/reader034/viewer/2022042715/5597a0da1a28abac098b4657/html5/thumbnails/3.jpg)
T h i s i s S c i e n c e B r a n d i n g ™
![Page 4: Shaw Science Case Studies](https://reader034.vdocuments.mx/reader034/viewer/2022042715/5597a0da1a28abac098b4657/html5/thumbnails/4.jpg)
Va l u e o f t h o u g h t l e a d e r r e l a t i o n s h i p s
![Page 5: Shaw Science Case Studies](https://reader034.vdocuments.mx/reader034/viewer/2022042715/5597a0da1a28abac098b4657/html5/thumbnails/5.jpg)
C u s t o m i z e d , U n i q u e S o l u t i o n s
![Page 6: Shaw Science Case Studies](https://reader034.vdocuments.mx/reader034/viewer/2022042715/5597a0da1a28abac098b4657/html5/thumbnails/6.jpg)
S t r a t e g i c p o s i t i o n i n g w i t h i n t h e s c i e n c e
![Page 7: Shaw Science Case Studies](https://reader034.vdocuments.mx/reader034/viewer/2022042715/5597a0da1a28abac098b4657/html5/thumbnails/7.jpg)
Making very complicated science understandable
![Page 8: Shaw Science Case Studies](https://reader034.vdocuments.mx/reader034/viewer/2022042715/5597a0da1a28abac098b4657/html5/thumbnails/8.jpg)
Exanta Case S tudy
T h i s i s w h a t w e d o .
![Page 9: Shaw Science Case Studies](https://reader034.vdocuments.mx/reader034/viewer/2022042715/5597a0da1a28abac098b4657/html5/thumbnails/9.jpg)
“Relaunching” a second-in-class product by uncovering new science
![Page 10: Shaw Science Case Studies](https://reader034.vdocuments.mx/reader034/viewer/2022042715/5597a0da1a28abac098b4657/html5/thumbnails/10.jpg)
Digging further into the science, we and discovered a strong case for dividing its target (the AT receptor)
into a “Good guy” (AT1) and a “Bad guy” (AT2)
![Page 11: Shaw Science Case Studies](https://reader034.vdocuments.mx/reader034/viewer/2022042715/5597a0da1a28abac098b4657/html5/thumbnails/11.jpg)
![Page 12: Shaw Science Case Studies](https://reader034.vdocuments.mx/reader034/viewer/2022042715/5597a0da1a28abac098b4657/html5/thumbnails/12.jpg)
Based upon bench science, we were able to make the claim that Diovan blocked AT2 but spared AT1 giving it a double benefit.
![Page 13: Shaw Science Case Studies](https://reader034.vdocuments.mx/reader034/viewer/2022042715/5597a0da1a28abac098b4657/html5/thumbnails/13.jpg)